Ignite Creation Date:
2024-05-05 @ 5:03 PM
Last Modification Date:
2024-10-26 @ 9:27 AM
Study NCT ID:
NCT00372905
Status:
TERMINATED
Last Update Posted:
2019-09-04
First Post:
2006-09-06
Brief Title:
Phase III Trial of VELCADE Plus Zevalin in Patients With Relapsed or Refractory Follicular Lymphoma
Sponsor:
Organization:
Northwestern University